查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842312

獸醫再生醫學市場規模、佔有率和趨勢分析報告：按動物、產品、最終用途、地區和細分市場預測，2025-2033年

Veterinary Regenerative Medicine Market Size, Share & Trends Analysis Report By Animal (Small Animals, Large Animals), By Product (Stem Cells, Others), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

獸醫再生醫學：市場概覽

全球獸醫再生醫學市場預計在 2024 年達到 3.3686 億美元，預計到 2033 年將達到 9.8785 億美元，2025 年至 2033 年的複合年成長率為 12.94%。

該市場的發展受到以下因素的推動：動物慢性病和退化性疾病的日益普遍、幹細胞和基因治療技術的進步、寵物日益人性化以及人們願意為先進的醫療保健付費。

伴侶動物和家畜中慢性、退化性和與老齡化相關的疾病（如骨關節炎、髖關節發育不良、肌腱損傷和脊椎疾病）的發病率不斷上升，推動了對動物再生醫學的需求。

骨關節炎（OA）是伴侶動物跛行和關節疾病的主要原因，佔80%，且由於肥胖和壽命延長，病例數不斷增加。在幼犬中，39.8%的犬隻在X光片上顯示患有骨關節炎，23.6%的犬隻表現出臨床症狀，這凸顯了該疾病患病率被低估的情況，以及早期發現以最佳化治療效果的必要性。飼主和獸醫正在尋求超越症狀治療、解決疾病根本原因的先進治療方法。幹細胞療法、富血小板血漿（PRP）和組織工程技術可望恢復動物功能、減輕疼痛並提高生活品質。隨著飼主對這些益處的認知不斷提高，相關療法的應用正在加速成長，為再生獸醫學創造了巨大的發展潛力。

基因療法和生醫材料的突破性進展，以及幹細胞分離、培養和遞送方法的持續創新，正顯著提高動物再生醫學的療效和安全性。例如，歐盟委員會核准了Arti-Cell Forte，這是由勃林格殷格翰和GST公司共同開發的首個基於幹細胞的動物用藥品，可為馬匹跛行提供即用型長期解決方案。細胞活力的提高、標靶遞送和微創應用技術的進步，正在擴大小型和大型動物可治療疾病的範圍。這些進展也降低了成本，使更多飼主能夠負擔得起治療。此外，獸醫臨床試驗和同儕審查證據的增加，增強了獸醫對再生療法的信心，促進了建議率的提高和市場的長期接受度。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章：獸醫再生醫學市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 獸醫再生醫學市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析
    • 法律規範
    • 科技趨勢分析
    • 定價分析
    • 產品平臺分析
    • 按地區和主要品種分類的動物數量估計（2024 年）

第4章：獸醫再生醫學市場：按動物類型分類的估算與趨勢分析

  • 細分儀表板
  • 獸醫再生醫學市場：波動分析（按動物類型分類）
  • 獸醫再生醫學市場規模及趨勢分析：依動物種類分類（2021-2033 年）
  • 小動物
  • 大型動物

第5章：獸醫再生醫學市場：依產品分類的估算與趨勢分析

  • 細分儀表板
  • 獸醫再生醫學市場：波動分析（依產品分類）
  • 獸醫再生醫學市場規模及產品趨勢分析（2021-2033）
  • 幹細胞
  • 其他

第6章：動物再生醫學市場：按應用分類的估算與趨勢分析

  • 細分儀表板
  • 獸醫再生醫學市場：按應用領域分類的趨勢分析
  • 獸醫再生醫學市場規模及應用趨勢分析（2021-2033）
    • 整形外科
    • 創傷/創傷護理
    • 其他

第7章：動物再生醫學市場：依最終用途分類的估算與趨勢分析

  • 細分儀表板
  • 獸醫再生醫學市場：依最終用途分類的變化分析
  • 獸醫再生醫學市場規模及趨勢分析（按最終用途分類）（2021-2033 年）
    • 獸醫醫院和診所
    • 獸醫研究所

第8章：獸醫再生醫學市場：區域估算與趨勢分析

  • 區域儀錶板
  • 按地區分類的獸醫再生醫學市場佔有率（2024 年和 2033 年）
  • 區域展望
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特
    • 卡達
    • 阿曼

第9章 競爭情勢

  • 市場參與企業分類
  • 企業市場分析/熱力圖分析
  • 公司簡介
    • Boehringer Ingelheim International GmbH.
    • Zoetis Services LLC
    • Dechra
    • Integra LifeSciences
    • Vetherapy
    • Vetstem, Inc.
    • Ardent
    • Enso Discoveries
    • Animal Cell Therapies, Inc.
    • Vetbiologics
    • Medrego
    • Celavet Inc
    • Strategy Mapping
    • Mergers &Acquisitions
    • Partnerships &Collaborations
    • Product launch
    • Others
  • 其他主要企業名單
Product Code: GVR-4-68040-043-0

Veterinary Regenerative Medicine Market Summary

The global veterinary regenerative medicine market size was estimated at USD 336.86 million in 2024 and is projected to reach USD 987.85 million by 2033, growing at a CAGR of 12.94% from 2025 to 2033. The market is advancing, driven by the rising prevalence of chronic and degenerative diseases in animals, advancements in stem cell and gene therapy technologies, growing humanization of pets, and the willingness to spend on advanced care.

The increasing incidence of chronic, degenerative, and age-related conditions such as osteoarthritis, hip dysplasia, tendon injuries, and spinal disorders in companion and livestock animals is driving demand for veterinary regenerative medicine.

Osteoarthritis (OA) causes 80% of lameness and joint disease in companion animals, with rising cases due to obesity and longer lifespans. In young dogs, 39.8% show radiographic OA and 23.6% clinical signs, emphasizing the underreported prevalence and the need for early detection to optimize treatment outcomes. Pet owners and veterinarians are seeking advanced treatment options beyond symptom management to address the root cause of disease. Stem cell therapy, platelet-rich plasma (PRP), and tissue engineering techniques offer the potential to restore function, reduce pain, and improve quality of life. As awareness of these benefits spreads among pet owners, adoption accelerates, creating strong growth potential in regenerative veterinary healthcare.

An increasing number of innovations in stem cell isolation, culture, and delivery methods, alongside breakthroughs in gene therapy and biomaterials, is significantly enhancing the efficacy and safety of veterinary regenerative medicine. For instance, the European Commission approved Arti-Cell Forte, the first stem cell-based veterinary product, offering a ready-to-use, long-term solution for equine lameness, developed by Boehringer Ingelheim and GST to address the underlying joint inflammation causes. Improvements in cell viability, targeted delivery, and minimally invasive application techniques are expanding the range of treatable conditions in small and large animals. These advancements also lower costs, making treatments more accessible to a wider population of pet owners. In addition, increasing veterinary clinical trials and peer-reviewed evidence are strengthening veterinarians' confidence in regenerative approaches, leading to higher recommendation rates and fostering long-term market adoption.

Global Veterinary Regenerative Medicine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary regenerative medicine market report based on animal, product, application, end use and region:

  • Animal Outlook (Revenue, USD Million, 2021 - 2033)
  • Small Animals
  • Large Animals
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Stem Cells
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Orthopedics
  • Trauma/Wound Care
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Hospitals/Clinics
  • Veterinary Research Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • India
    • China
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Regenerative Medicine Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of chronic and degenerative diseases in animals
      • 3.2.1.2. Advancements in stem cell and gene therapy technologies
      • 3.2.1.3. Growing humanization of pets and willingness to spend on advanced care
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High treatment costs and limited accessibility
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Regenerative Medicine Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Technology Trend Analysis
    • 3.3.5. Pricing Analysis
    • 3.3.6. Product Pipeline Analysis
    • 3.3.7. Estimated Animal Population by region, key species, 2024

Chapter 4. Veterinary Regenerative Medicine Market: Animal Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Regenerative Medicine Market: Animal Movement Analysis
  • 4.3. Veterinary Regenerative Medicine Market Size & Trend Analysis, by Animal, 2021 to 2033 (USD Million)
  • 4.4. Small Animals
    • 4.4.1. Small Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Large Animals
    • 4.5.1. Large Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Veterinary Regenerative Medicine Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Regenerative Medicine Market: Product Movement Analysis
  • 5.3. Veterinary Regenerative Medicine Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 5.4. Stem Cells
    • 5.4.1. Stem Cells Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Veterinary Regenerative Medicine Market: By Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Regenerative Medicine Market: By Application Movement Analysis
  • 6.3. Veterinary Regenerative Medicine Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
    • 6.3.1. Orthopedics
      • 6.3.1.1. Orthopedics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Trauma/Wound Care
      • 6.3.2.1. Trauma/Wound Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Others
      • 6.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Veterinary Regenerative Medicine Market: By End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Veterinary Regenerative Medicine Market: By End Use Movement Analysis
  • 7.3. Veterinary Regenerative Medicine Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
    • 7.3.1. Veterinary Hospitals & Clinics
      • 7.3.1.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Veterinary Research Institutes
      • 7.3.2.1. Veterinary Research Institutes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Veterinary Regenerative Medicine Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Veterinary Regenerative Medicine Market Share, By Region, 2024 & 2033 (USD Million)
  • 8.3. Regional Outlook
  • 8.4. North America
    • 8.4.1. North America Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. U.S. Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Canada Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Mexico Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. UK Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Germany Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. France Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Italy Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Spain Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Denmark Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Sweden Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Norway Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Japan Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. China Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. India Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Australia Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. South Korea Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Thailand Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Brazil Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Argentina Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Middle East & Africa
    • 8.8.1. Middle East & Africa Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. South Africa Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Saudi Arabia Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. UAE Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Kuwait Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.6. Qatar
      • 8.8.6.1. Key Country Dynamics
      • 8.8.6.2. Competitive Scenario
      • 8.8.6.3. Qatar Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.7. Oman
      • 8.8.7.1. Key Country Dynamics
      • 8.8.7.2. Competitive Scenario
      • 8.8.7.3. Oman Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Position Analysis/ Heat Map Analysis
  • 9.3. Company Profiles
    • 9.3.1. Boehringer Ingelheim International GmbH.
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Zoetis Services LLC
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Dechra
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Integra LifeSciences
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Vetherapy
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Vetstem, Inc.
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Ardent
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Enso Discoveries
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Animal Cell Therapies, Inc.
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Vetbiologics
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Medrego
      • 9.3.11.1. Participant's Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Product Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Celavet Inc
      • 9.3.12.1. Participant's Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Product Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Strategy Mapping
    • 9.3.14. Mergers & Acquisitions
    • 9.3.15. Partnerships & Collaborations
    • 9.3.16. Product launch
    • 9.3.17. Others
  • 9.4. List of other key players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Veterinary Regenerative Medicine Market, by region, 2021 - 2033 (USD Million)
  • Table 3 Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 4 Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 5 Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 6 Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 7 North America Veterinary Regenerative Medicine Market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 9 North America Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 10 North America Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 11 North America Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 12 U.S. Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 13 U.S. Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 15 U.S. Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 16 Canada Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 17 Canada Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 18 Canada Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 19 Canada Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 20 Mexico Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 21 Mexico Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 22 Mexico Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 23 Mexico Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 24 Europe Veterinary Regenerative Medicine Market, by country, 2021 - 2033 (USD Million)
  • Table 25 Europe Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 26 Europe Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 27 Europe Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 28 Europe Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 29 Germany Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 30 Germany Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 31 Germany Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 32 Germany Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 33 UK Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 34 UK Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 35 UK Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 36 UK Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 37 France Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 38 France Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 39 France Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 40 France Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 41 Italy Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 42 Italy Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 43 Italy Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 44 Italy Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 45 Spain Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 46 Spain Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 47 Spain Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 48 Spain Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 49 Denmark Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 50 Denmark Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 51 Denmark Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 52 Denmark Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 53 Sweden Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 54 Sweden Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 55 Sweden Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 56 Sweden Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 57 Norway Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 58 Norway Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 59 Norway Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 60 Norway Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Veterinary Regenerative Medicine Market, by country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 66 China Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 67 China Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 68 China Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 69 China Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 70 Japan Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 71 Japan Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 72 Japan Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 73 Japan Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 74 India Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 75 India Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 76 India Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 77 India Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 78 South Korea Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 79 South Korea Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 80 South Korea Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 81 South Korea Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 82 Australia Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 83 Australia Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 84 Australia Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 85 Australia Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 86 Thailand Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 87 Thailand Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 88 Thailand Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 89 Thailand Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 90 Latin America Veterinary Regenerative Medicine Market, by country, 2021 - 2033 (USD Million)
  • Table 91 Latin America Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 92 Latin America Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 93 Latin America Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 94 Latin America Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 95 Brazil Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 96 Brazil Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 97 Brazil Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 98 Brazil Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 99 Argentina Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 100 Argentina Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 101 Argentina Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 102 Argentina Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 103 MEA Veterinary Regenerative Medicine Market, by country, 2021 - 2033 (USD Million)
  • Table 104 MEA Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 105 MEA Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 106 MEA Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 107 MEA Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 108 South Africa Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 109 South Africa Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 110 South Africa Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 111 South Africa Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 116 UAE Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 117 UAE Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 118 UAE Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 119 UAE Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 120 Kuwait Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 124 Qatar Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 125 Qatar Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 126 Qatar Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 127 Qatar Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 128 Oman Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 129 Oman Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 130 Oman Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 131 Oman Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 132 Company Overview
  • Table 133 Product Benchmarking
  • Table 134 Financial Performance
  • Table 135 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Veterinary Regenerative Medicine Market revenue, 2021 - 2033 (USD Million)
  • Fig. 10 Veterinary Regenerative Medicine Market snapshot
  • Fig. 11 Veterinary Regenerative Medicine Market driver impact
  • Fig. 12 Veterinary Regenerative Medicine Market restraint impact
  • Fig. 13 Veterinary Regenerative Medicine animal key takeaways (USD Million)
  • Fig. 14 Veterinary Regenerative Medicine Market: animal, market share 2024 & 2033
  • Fig. 15 Small Animals market, 2021 - 2033 (USD Million)
  • Fig. 16 Large Animals market, 2021 - 2033 (USD Million)
  • Fig. 17 Veterinary Regenerative Medicine Market Product key takeaways (USD Million)
  • Fig. 18 Veterinary Regenerative Medicine Market: Product, market share 2024 & 2033
  • Fig. 19 Stem Cells market, 2021 - 2033 (USD Million)
  • Fig. 20 Others market, 2021 - 2033 (USD Million)
  • Fig. 21 Veterinary Regenerative Medicine market by application: Key takeaways
  • Fig. 22 Veterinary Regenerative Medicine market by application, market share, 2024 & 2033
  • Fig. 23 Orthopedics market, 2021 - 2033 (USD Million)
  • Fig. 24 Trauma/Wound Care market, 2021 - 2033 (USD Million)
  • Fig. 25 Others market, 2021 - 2033 (USD Million)
  • Fig. 26 Veterinary Regenerative Medicine market by End Use: Key takeaways
  • Fig. 27 Veterinary Regenerative Medicine market by End Use, market share, 2024 & 2033
  • Fig. 28 Veterinary hospitals & clinics market, 2021 - 2033 (USD Million)
  • Fig. 29 Veterinary Research Institutes market, 2021 - 2033 (USD Million)
  • Fig. 30 Regional market place: Key takeaways
  • Fig. 31 Regional outlook, 2024 & 2033
  • Fig. 32 North America Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 34 Canada Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 35 Mexico Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 36 Europe Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 37 UK Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 38 Germany Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 39 France Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 40 Italy Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 41 Spain Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 42 Denmark Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 43 Sweden Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 44 Norway Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 45 Asia Pacific Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 46 Japan Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 47 China Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 48 India Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 49 Australia Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 50 South Korea Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 51 Thailand Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 52 Latin America Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 53 Brazil Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 54 Argentina Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 55 MEA Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 56 South Africa Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 57 Saudi Arabia Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 58 UAE Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 59 Kuwait Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 60 Qatar Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 61 Oman Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 62 Market participant categorization